Our History
Himont was established in 1994 by group of professionals mostly returning form USA after completing their education and several years of experience with multinationals, i.e. Glaxo, Upjohn, Novartis, Aventis, Servier and Rhone Poulenc.
The chairman of the group, Dr. M. Umar is a leading orthopedic Surgeon Professor at a prestigious national university , the Agha Khan Medical Institution. Himont is not owned by a single family, it is was created as an institution. The President & CEO Mr. Intesar Siddiqui, was educated at Columbia University New York worked with Upjohn Company for over twenty-two years both at domestic and international operations, including the USA. The last position he held with UpJohn as a regional Director for the South Asia .
The primary objective of the group was to establish high quality branded generics company, represent multinationals not operating directly in Pakistan and to establish a FDA and European specifications bulk drug plant.
In last Seventeen years, Himont has moved forward considerably and has established two manufacturing facilities. Himont Chemical built one of the largest bulk raw materials manufacturing plants in the country, which had seven hundred tons annual capacity. it was established at a site of 12 acres to produce USP/ BP standards Ibuprofen, Sulphamethoxazole, Ciprofloxacian, Ampicillian, and Cloxacillin. The plant raw materials to one hundred and twenty companies including multinationals like Glaxo / Wellcome, Knoll, Roche, Organon, Reckitt & Colman, Rhone Poulenc and several other local companies. Later it was sold to another company.
In 2007 Himont has built another unique boutique plant to manufacture bulk chemicals for both Cardiovascular and Iron Complex nutritional compounds (Iron Protein succinylate). It meets all the international GMP standards. We are exporting raw material to multinationals in Europe as well as in other regions.
The second plant is manufacturing / repacking non-sterile and sterile products. Currently, Himont Pharmaceuticals (PVT.) Limited is manufacturing and promoting eighty different formulations. These products include under license arrangements with leading European companies, i.e Himalaya Drug co. (herbal products) of USA, Nutribio France and HOCHDORF Swiss. Himont has established its own distribution company with nine centers in major cities, and directly supplies products to over thirty thousand pharmacies throughout the country.
In the local market, Himont is considered as a fast growing company with excellent quality image. According to the latest edition of IMS, Himont is rated among top forty companies out of 550 pharmaceutical companies operating in Pakistan.
According to IMS audits, more than sixty percent of the local physicians, at least once a week prescribe Himont Pharmaceuticals products, particularly in the teaching institutions. If one includes raw material purchased from Himont Chemicals, more than 80% physician prescriptions in Pakistan contain Himont products.
In 2009 Himont open the new door in the nutraceuticals market and started with the products Epitize. We establish a separate manufacturing facility for the herbal division. Recently we have entered into dairy based nutrition products and infant milk formulation with the help of European multinationals.
The Company has strength of over eight hundred employees, including qualified professionals from various fields of expertise. The company maintains its own separate Human Resource Development Center, since its management believes that its employees are its biggest assets. As part of its governance policy the management is committed towards the continuous education of personals and has established its own Human Resource Department Center. The company has also established a state of art laboratory to ensure quality control and quality products.
About Us
Himont has established itself among the medical community as a responsible and professional partner with quality products and services. Within short span of Seventeen Years Himont has established itself as market leader in certain formulations, causing other companies to test their quality against Himont products.
It is the only pharmaceutical company in the country which has the capability to manufacture bulk chemicals finished pharmaceuticals and conduct self distribution.
The future of the national healthcare industry in Pakistan is exciting and challenging. It would be difficult for the national industry to acquire the latest molecules, after the implementation of WTO and GATT. Despite the fact, the pharmaceutical industry will continue to expand at an average rate of ten percent [10%] per annum for the nest ten years the demand for quality products will also increase rapidly the expectations of the physicians and the government will raise the bar on the current standard of performance therefore quality human capital will play a vital role in the success of any healthcare organization.
Himont''s primary focus will be to ensure its productivity per employee and efficient utilization of its finances in order to meet the future challenges Himont will continuously invest in upgrading its human resource and systems in order to remain competitive. Himont will also continuously search for the latest technologies and international business collaborations.
Himont after satisfactory growth in the last seventeen years will try to open new markets beyond the national boarders, while fulfilling the needs of the local collaborations.
While the Himont team is confident to meet the future challenges, it also keeps an eye on the constant concern for excellence while serving the physicians and patients with the utmost care and professionalism.
